Heterogeneous Off-Target Effects of Ultra-Low Dose Dimethyl Sulfoxide (DMSO) on Targetable Signaling Events in Lung Cancer In Vitro Models
Authors:
- Elisa BaldelliEBElisa Baldelli
- Mahalakshmi SubramanianMSMahalakshmi Subramanian
- Abduljalil M. AlsubaieAAAbduljalil M. Alsubaie
- Guy OldakerGOGuy Oldaker
- Maria EmelianenkoMEMaria Emelianenko
- Emna El GazzahEGEmna El Gazzah
- Sara BaglivoSBSara Baglivo
- Kimberley A. HodgeKHKimberley A. Hodge
- Fortunato BianconiFBFortunato Bianconi
- Vienna LudoviniVLVienna Ludovini
- Lucio Crino’LCLucio Crino’
- Emanuel F. PetricoinEPEmanuel F. Petricoin
Open Access
- 10 March 2021
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (6) , 2819
Abstract
Targetable alterations in cancer offer novel opportunities to the drug discovery process. However, pre-clinical testing often requires solubilization of these drugs in cosolvents like dimethyl sulfoxide (DMSO). Using a panel of cell lines commonly used for in vitro drug screening and pre-clinical testing, we explored the DMSO off-target effects on functional signaling networks, drug targets, and downstream substrates. Eight Non-Small Cell Lung Cancer (NSCLC) cell lines were incubated with three concentrations of DMSO (0.0008%, 0.002%, and 0.004% v/v) over time. Expression and activation levels of 187 proteins, of which 137 were kinases and downstream substrates, were captured using the Reverse Phase Protein Array (RPPA). The DMSO effect was heterogeneous across cell lines and varied based on concentration, exposure time, and cell line. Of the 187 proteins measured, all were statistically different in at least one comparison at the highest DMSO concentration, followed by 99.5% and 98.9% at lower concentrations. Only 46% of the proteins were found to be statistically different in more than 5 cell lines, indicating heterogeneous response across models. These cell line specific alterations modulate response to in vitro drug screening. Ultra-low DMSO concentrations have broad and heterogeneous effects on targetable signaling proteins. Off-target effects need to be carefully evaluated in pre-clinical drug screening and testing.Keywords
Funding Information
- Associazione Italiana per la Ricerca sul Cancro (15713/2014)
This publication has 41 references indexed in Scilit:
- Influence of Dimehylsulfoxide on Protein–Ligand Binding AffinitiesAnalytical Chemistry, 2013
- Differential network entropy reveals cancer system hallmarksScientific Reports, 2012
- Effects of Dimethyl Sulfoxide in Cholesterol-Containing Lipid Membranes: A Comparative Study of Experiments In Silico and with CellsPLOS ONE, 2012
- Dimethyl Sulfoxide Induces Both Direct and Indirect Tau HyperphosphorylationPLOS ONE, 2012
- Complexity in the signaling network: insights from the use of targeted inhibitors in cancer therapyGenes & Development, 2012
- Molecular Basis for Dimethylsulfoxide (DMSO) Action on Lipid MembranesJournal of the American Chemical Society, 2006
- Dimethyl sulfoxide binding to globular proteins: A nuclear magnetic relaxation dispersion studyProtein Science, 1997
- Stimulation of tyrosine protein kinase activity by dimethyl sulfoxideBiochemical and Biophysical Research Communications, 1985
- Solvent interactions with test compounds and recommendations for testing to avoid artifactsEnvironmental Mutagenesis, 1985
- DMSO increases tyrosine residue phosphorylation in membranes from murine erythroleukemia cellsBiochemical and Biophysical Research Communications, 1983